The GLP-1 fatigue guide discusses this issue comprehensively
Since going public in 2021 through a $1.6 billion SPAC deal, its grown into a major telehealth company, expanding into mental health and dermatology although Hims continues to post videos about, well: On May 20, Hims announced it would also sell its own version of GLP-1 weight loss injections like Ozempic and Wegovy
Mushenkova NV, Bezsonov EE, Orekhova VA, Popkova TV, Starodubova AV, Orekhov AN
Over the last several years, GLP-1 prescriptions have surged because these drugs are widely discussed not only for diabetes control but also for weight loss and long-term chronic weight management, including use patterns that expanded public awareness and demand
You can opt-out at any time.